Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

RIGLRIGL
6 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in RIGEL PHARMACEUTICALS INC

BANK OF AMERICA CORP /DE/ holds 144,131 shares of RIGL (RIGEL PHARMACEUTICALS INC), worth $3.9M as of 2026-Q1. The position was increased (+23.2% shares). RIGL represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$3.9M

Current Shares

144,131

Total Value Change

+$3.4M

Total Shares Change

+111,965

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
144,131
+23.2%
$3.9M0.0%$33.02
32
2025-Q4
Increased
116,952
+55.0%
$5M0.0%$42.83
38
2025-Q3
Decreased
75,476
-59.8%
$2.1M0.0%$28.75
0
2025-Q2
Increased
187,621
+41.7%
$3.5M0.0%$19.48
35
2025-Q1
Increased
132,437
+311.7%
$2.4M0.0%$17.88
42
2024-Q4
New
32,166
-
$541,0320.0%$16.47
37

Other major holders of RIGL: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used